What Smart TMS does

Smart TMS (legal entity Smart rTMS Ltd, company number 09921994) is a UK-based private healthcare provider founded in 2015 by Gerard Barnes and Dr Leigh A Neal, operating the largest dedicated Transcranial Magnetic Stimulation (TMS) clinic network in the UK and Ireland across 10 locations (Birmingham, Bristol, Edinburgh, London, Manchester, Newcastle, Northampton, Southampton, St Albans, and Dublin). The company's core technology is repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive neuromodulation procedure in which electromagnetic coils placed against the scalp stimulate targeted brain regions to treat depression, anxiety, OCD, PTSD, addiction, and other mental health conditions that have not responded to medication or psychotherapy. The service portfolio has expanded beyond standard TMS to include Accelerated TMS protocols, Neurofeedback as a complementary drug-free therapy, a Continuous Care aftercare programme sold in discounted session blocks, tele-psychiatry video assessments, and a CPD-certified 'Introduction to TMS' clinician training course.

The business operates a hybrid direct-to-consumer and clinician-referred model: patients can self-refer via an online suitability checker, free consultation booking, and brochure downloads, while GPs, psychiatrists, psychologists, and nurses drive professional referrals through dedicated channels, practising privileges, and shared-care arrangements. Revenue is generated primarily from per-session TMS treatment (typically 15-30 sessions per course), non-refundable initial consultation fees, Continuous Care top-up packages, professional training course fees, and reimbursements from multiple UK private medical insurers. The company has treated more than 1,000 patients cumulatively since 2015, with approximately 70% treated for clinical depression, holds CQC registration, and is part of the international neurocare group network alongside affiliated clinics in the Netherlands, the United States, and Australia.

Name

Smart TMS

Legal name

Smart rTMS Ltd

Website

https://smarttms.co.uk

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Smart TMS operates the UK's and Ireland's largest dedicated Transcranial Magnetic Stimulation (TMS) clinic network across 10 locations, providing non-invasive neuromodulation therapy to adults and adolescents with treatment-resistant depression, anxiety, OCD, PTSD, and addiction, supplemented by Neurofeedback, Continuous Care aftercare, tele-psychiatry, and CPD-certified clinician training.

Ownership category

akta.pro rank

Product category

Mental Health Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

akta.pro secondary industry

Neurology Telemedicine Platforms (HLALAGAC)

Keywords

• TMS therapy
• Depression treatment
• Neuromodulation services
• Mental health clinics
• Transcranial magnetic stimulation

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. TMS Treatment Sessions: Patients pay per session at an applicable rate quoted following initial consultation. Treatment typically involves 15–30 sessions per course, each lasting approximately 30 minutes. Session blocks are also available under the Continuous Care aftercare programme at discounted rates.
2. Clinical Consultations: Initial consultation fees charged for pre-procedure assessment of patient suitability. These fees are non-refundable as they cover clinician time, clinical assessment, and subsequent treatment reviews. Follow-up reviews are included as part of the patient's ongoing care.
3. Continuous Care (Top-up Sessions): Ongoing top-up TMS sessions sold in blocks (10, 20, or 30 sessions) at discounted rates, providing recurring revenue from existing patients post-initial treatment course.
4. Professional Training Courses: Revenue generated from TMS prescriber training courses ('Introduction to TMS') offered to healthcare professionals including GPs, psychiatrists, psychologists, and nurses.
5. Private Medical Insurance Billing: Treatment costs covered through private medical insurance providers. The company works with multiple UK private medical insurers who reimburse TMS treatment costs for eligible patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Smart TMS provides Transcranial Magnetic Stimulation (TMS) therapy as a non-invasive, medication-free neuromodulation procedure using electromagnetic coils placed against the scalp to stimulate targeted brain regions for treating depression, anxiety, OCD, PTSD, and addiction. The company operates the UK's largest network of dedicated TMS clinics with ten locations across the UK and Ireland, supplemented by tele-psychiatry consultations, Neurofeedback as a complementary service, a Continuous Care aftercare programme of top-up session blocks, and CPD-certified professional training for clinicians.

Product overview

Smart TMS is a healthcare provider offering Transcranial Magnetic Stimulation (TMS) therapy as its core treatment, a non-invasive, medication-free procedure that uses pulsing magnetic fields to stimulate brain pathways for mental health conditions. The company operates as a platform-plus-services model, with the main TMS Therapy product supplemented by Accelerated TMS protocols for intensive treatment, Neurofeedback as an alternative drug-free therapy, Continuous Care aftercare packages for long-term maintenance, professional TMS Prescriber Training courses, and Tele-Psychiatry video consultations for patient assessment. Founded in 2015, Smart TMS is the UK's largest network of TMS clinics treating depression, anxiety, OCD, PTSD, addiction, and other conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Transcranial Magnetic Stimulation (TMS) Therapy Non-invasive treatment using pulsing magnetic fields delivered via electromagnetic coils to stimulate brain regions associated with mental health conditions such as depression, anxiety, OCD, PTSD, and addiction disorders. Sessions last approximately 30 minutes and are delivered across ten owned clinic locations in the UK and Ireland, supplemented by tele-psychiatry assessment.
• Accelerated TMS

Quantifiable outcome

• Majority of patients go into remission following TMS therapy
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor and core.

• NHS Foundation TrustminorStrategic or Co-development PartnerSmart TMS shares patient personal and medical information with NHS Foundation Trusts for collaborative care purposes where applicable, as described in their terms and conditions and privacy policy. This is a care coordination partnership rather than a formal strategic alliance.
• neurocare Group (International)coreStrategic or Co-development PartnerSmart TMS is part of the neurocare group network, with partner clinics in the Netherlands, United States, and Australia. This relationship provides international brand affiliation, shared best practices in neuromodulation, and enables referrals for patients travelling between countries.
• UK Private Medical InsurerscoreChannel Partner/ Reseller/ DistributorSmart TMS works with multiple UK private medical insurance providers who cover TMS treatment costs for eligible patients. The company maintains a dedicated private insurers page listing covered providers.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• neurocare Group: International parent network of TMS and neuromodulation clinics operating in the Netherlands, Australia, and the US (e.g., NeuroCare Centers of America). Smart TMS is part of this network, so neurocare is the umbrella group and the most directly comparable international peer in terms of clinical model and patient base.
• Priory Group: One of the UK's largest private mental health and addiction treatment providers, offering inpatient and outpatient services including TMS in select locations. Comparable as a UK private mental health services incumbent targeting treatment-resistant patients, though broader in scope than Smart TMS.
• Cygnet Health Care: Major UK provider of mental health services including specialised treatment for depression, OCD, and addiction. Comparable as a UK-wide mental health services peer, though broader in scope; some overlap in treatment-resistant patient pool targeted by Smart TMS.
• Neuronetics: US-listed manufacturer of NeuroStar TMS systems and operator/proponent of TMS therapy networks. Comparable as a TMS ecosystem player, though Neuronetics is primarily a device manufacturer rather than a clinic operator; useful as a public-market TMS benchmark.
• Brainsway: Israel-based medical device company commercialising deep TMS systems for depression, OCD, and addiction. Comparable as a TMS technology company serving the same clinical indications Smart TMS treats, though focused on device sales rather than clinic operations.

Direct peers

• The London Psychiatry Centre: London-based private mental health clinic offering TMS and other treatments for depression, anxiety, and related conditions. Direct UK competitor serving the same affluent private-pay and insured patient pool in the same geography as Smart TMS London.

Others

• Magstim: UK-based manufacturer of TMS stimulators and coils used in clinical and research settings. Comparable as a UK-headquartered TMS technology provider; an enabler/supplier in the TMS ecosystem rather than a direct service competitor.
• BUPA (UK private medical insurer): Major UK private medical insurer that reimburses TMS treatment for eligible policyholders. Comparable as a payer/channel partner rather than a competitor; important to Smart TMS's revenue model and a useful counterpart in any reimbursement or contracting strategy.

Emerging players

• Flow Neuroscience: Sweden/UK-based provider of at-home transcranial direct current stimulation (tDCS) device and digital therapeutic for depression. Comparable as an adjacent emerging non-invasive neurostimulation entrant targeting the same treatment-resistant depression patient pool with a lower-cost home-based model.
• Psilocybin/ketamine clinic operators (e.g., COMPASS Pathways-adjacent clinics): A growing cohort of UK private clinics offering ketamine or psychedelic-assisted therapy for treatment-resistant depression. Comparable as emerging alternative-modality peers competing for the same private-pay treatment-resistant depression patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/SmarttmsUk
• Facebookfacebook.com/SmartTMS
• LinkedInlinkedin.com/company/smart-tms
• Instagraminstagram.com/smart_tms
• Xx.com/Smart_TMS

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smart TMS